Veracyte, Inc. (VCYT)
- Sector
- Biotechnology
- Last price
- $24.01
- As of
Kresmion compiles this page from VCYT's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
VERACYTE, INC. (VCYT): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-05.
See the full VCYT dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for VCYT on one page. Preview it with sample data, then open it live with a free account.
Preview the VCYT dossierActive events for VCYT
- mediumEarnings above estimates
Q3-2026: Beat consensus by 21.8%, EPS $0.51 vs $0.4188 estimate
- high13F: large increase
Point72 Asset Management, L.P. added +52% to VCYT (2026Q2)
- high13F: large reduction
MILLENNIUM MANAGEMENT LLC cut 66% of VCYT (2026Q2)
- high13F: large reduction
MILLENNIUM MANAGEMENT LLC cut 51% of VCYT (2026Q2)
- high13F: large increase
D. E. Shaw & Co., Inc. added +880% to VCYT (2026Q2)
FREE, NO ACCOUNT
Every event on VCYT, as it fires
You are seeing 5 of 16 events recorded on VCYT since 2026-05-26.
The five above landed across 2 days. The other 11 were recorded on 3 other days. 9 of the 16 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, VCYT
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
More data on VCYT
VCYT against its peers
VCYT's operating margin of 11.2% ranks in the 78th percentile of 15 Biotechnology sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-03-31.
| Metric | VCYT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 517M USD | 74.7M USD | 84 | 15 |
| Gross margin | 70.1% | 88.3% | 19 | 7 |
| Operating margin | 11.2% | -148.6% | 78 | 15 |
| Net margin | 12.8% | -210.6% | 79 | 16 |
| Return on equity | 5.1% | -36.9% | 86 | 17 |
| P / E | 29.3x | n/a | n/a | 2 |
| 1 year | -41.2% | 2.8% | 8 | 19 |
Peers (19): SEPN, BCRX, MAZE, REPL, AGIO, AUPH, ZBIO, STOK, LKFT, BHVN, ZYME, VERA, NRIX, CLDX, IMNM, MESO, RARE, VIR, RXRX. Left out: TRAX (no annual filing), COAG (no annual filing), GENB (no annual filing), KLRA (no annual filing), ZLDPF (no annual filing), BRVE (no annual filing). Fiscal periods ending between 2025-06-30 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (VCYT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Cite this data
Kresmion counts the managers it follows that reported a non-option position in VCYT on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on VCYT in the last 180 days.
Upstream: SEC EDGAR filings for VCYT
Kresmion, "VERACYTE, INC. (VCYT) institutional holdings and SEC filings", data as of 2026-11-10, https://kresmion.com/research/VCYT. Upstream data: SEC EDGAR filings for VCYT.
Link to this data (HTML):
<a href="https://kresmion.com/research/VCYT">VERACYTE, INC. (VCYT) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow VCYT on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to VCYT for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.